Summary information by reportable segment is as follows:


	UTI		Concorde		Corporate		Consolidated
Three Months Ended June 30, 2025
Revenues	$	131,463	$	72,835	$	—	$	204,298
Income (loss) from operations	19,870		5,929		(11,647)		14,152
Depreciation and amortization	6,068		1,939		308		8,315
Net income (loss)	18,583		5,890		(13,810)		10,663

Three Months Ended June 30, 2024
Revenues	$	117,134	$	60,324	$	—	$	177,458
Income (loss) from operations	14,136		3,716		(10,406)		7,446
Depreciation and amortization	5,743		1,367		266		7,376
Net income (loss)	12,673		3,778		(11,466)		4,985

Nine Months Ended June 30, 2025
Revenues	$	397,169	$	216,005	$	—	$	613,174
Income (loss) from operations	66,762		26,006		(34,285)		58,483
Depreciation and amortization	18,010		5,499		943		24,452
Net income (loss)	63,090		25,892		(44,720)		44,262


	UTI		Concorde		Corporate		Consolidated
Nine Months Ended June 30, 2024
Revenues	$	355,831	$	180,498	$	—	$	536,329
Income (loss) from operations	47,309		14,091		(28,531)		32,869
Depreciation and amortization	16,921		3,738		903		21,562
Net income (loss)	42,886		14,271		(33,996)		23,161

As of June 30, 2025
Total assets	$	463,179	$	134,184	$	143,396	$	740,759

As of September 30, 2024
Total assets	$	440,764	$	125,212	$	178,599	$	744,575